A month has gone by since the last earnings report for Idex (IEX) . Shares have added about 4.5% in that time frame, outperforming the S&P 500.Will the recent positive trend continue leading up to its next earnings release, or is Idex due for a pullback? Before we dive into how investors and analysts have reacted as of late, let's take a quick look at the most recent earnings report in order to get a better handle on the important drivers. IDEX Q2 Earnings Top Estimates, Sales Miss, '24 View DownIDEX’s seco ...

Reference is made to the notice on 29 August 2024 regarding settlement of a term payment on a convertible loan by issue of 9,123,333 shares at NOK 0.60 per share. The share capital has been registered and the shares will be delivered soonest. Following the issue, the company's share capital is NOK 50,812,483.20 divided into 338,749,888 shares, each with a nominal value of NOK 0.15. For further information contact:Marianne Bøe, Investor RelationsE-mail: marianne.boe@idexbiometrics.comTel: +47 918 00186 Ab ...

The board of directors of IDEX Biometrics ASA has resolved to issue 1,500,000 incentive subscription rights (SRs) to the CEO of the IDEX Biometrics group. The grant was made under the company's 2024 incentive subscription rights plan as resolved at the annual general meeting on 16 May 2024. The exercise price of the SRs is NOK 0.93 per share. The SRs vest by 25% per year over four years and expire on 16 May 2029. Following this grant there are 28,729,855 incentive subscription rights outstanding in IDEX Bi ...

Oslo, Norway, 28 August 2024 – IDEX Biometrics is bringing biometric authentication onto payment cards for the Indian market, together with a worldwide leader in payment services. India boasts more than 1 billion payment cards in circulation and has been a frontrunner in biometrics for many years. Live user experience and technology testing for the IDEX Pay biometric payment cards has been conducted with our Indian payment service partner, giving excellent results, and proving that biometric payment cards c ...

Reference is made to IDEX Biometrics ASA’s disclosure today of a private placement of shares. IDEX Biometrics discloses the following information on behalf of a primary insider. IDEX Biometrics CEO, Catharina Eklof, subscribed to 666,666 shares, ISIN NO0013107490, at NOK 0.60 per share. Contact personMarianne Bøe, Head of Investor RelationsE-mail: marianne.boe@idexbiometrics.com  Tel: +47 9180 0186 About IDEX BiometricsIDEX Biometrics ASA (OSE: IDEX) is a global technology leader in fingerprint biometrics ...

IDEX Biometrics ASA has completed a private placement of new shares in the company after market close 19 August 2024 by an accelerated book build. The private placement amounts to 16,166,667 shares at NOK 0.60 per share, raising NOK 9.7 million before expenses. The net proceeds from the private placement will be used to general corporate purposes. The payment date is 21 August 2024 and the shares are expected to be delivered on 23 August 2024. Following private placement, IDEX Biometrics ASA’s share capital ...

Oslo, Norway – 19 August 2024 – IDEX Biometrics has appointed Catharina Eklof as the new Chief Executive Officer, effective as of today.   Catharina Eklof has for the last three years served as Chief Commercial Officer for IDEX Biometrics, and has been instrumental in the transformation from a component provider to a full biometric solution company. Catharina brings global experience in business transformation and has been driving profitable growth initiatives and led commercialization of new technology sol ...

文章核心观点 - IDEX公司近期的经营表现未能令投资者满意,主要由于各业务板块疲软以及销售、管理和行政费用上升[1][2] - 公司广泛的国际业务使其面临外汇风险的不确定性[6] 业务表现分析 - 健康与科技技术(HST)和流体与计量技术(FMT)两大板块销量疲软 - HST板块受到分析仪器、生命科学和半导体市场疲软的影响,第二季度收入下降11%[3] - FMT板块受到工业市场非重复性项目和农业业务周期性下滑的拖累,第二季度收入下降2%[4] - 公司预计2024年有机收入将同比下降1-2%[4] 费用上升压力 - 销售、管理和行政费用持续上升,第二季度同比增长4.9%,占销售比重增加200个基点至22.6%[5] - 摊销费用上升、专业服务和自主支出增加是主要原因[5] 外汇风险 - 公司广泛的国际业务使其面临美元升值带来的价格上调或利润率压缩的风险[6] - 第二季度外汇折算对销售额产生1%的负面影响[6] 业绩预期下调 - 过去60天内,市场预期公司2024年盈利下调4.6%[7]

Oslo, Norway – 15 August 2024 - IDEX Biometrics ASA’s interim report for the first half of 2024 is attached to this notice (link below). The interim report is also available on the IDEX Biometrics website: www.idexbiometrics.com/investors/interim-results/ A webcast presentation of the interim report will be held by Vince Graziani, Chief Executive Officer, today at 09:00 CET. The webcast presentation slide deck is also attached to this notice (link below).Link to webcast: https://idexbiometrics.videosync.fi ...

文章核心观点 - IDEX Biometrics ASA决定不进行后续发行 [1][2] - 公司股票在私募配售价格以下交易一段时间且交易量足够,股东可以在市场上以低于后续发行价格的价格购买股票,从而降低私募配售的摊薄效应 [2] 公司信息 - IDEX Biometrics ASA是一家全球指纹生物识别技术领导者,提供支付、访问控制和数字身份认证解决方案 [4] - 公司的生物识别解决方案基于专利和专有传感器技术、集成电路设计和软件,主要面向基于卡的支付和数字认证应用 [4] - 公司作为行业推动者与领先的卡制造商和技术公司合作,将解决方案推向市场 [4] 公告信息 - 该公告由IDEX Biometrics ASA的财务副总裁Erling Svela于2024年8月14日23:45 CET发布 [5] - 该信息根据挪威证券交易法第5-8条和第5-12条进行披露和发布 [5]